Hc Biopharma Inc.
Clinical trials sponsored by Hc Biopharma Inc., explained in plain language.
-
New drug combo hopes to shrink lung tumors
Disease control Recruiting nowThis early-stage study tests a new drug called HC010 combined with chemotherapy in people with advanced lung cancer. The main goal is to find a safe dose and see if the combination helps control the disease. About 328 participants will take part.
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
New hope for lung cancer: experimental drug HC010 enters phase 2 trial
Disease control Recruiting nowThis study tests a new drug called HC010 in 50 people with advanced non-small cell lung cancer that has a specific marker (PD-L1 positive). The goal is to see if the drug can shrink tumors and how safe it is. Participants receive HC010 as their first treatment, and researchers wi…
Phase: PHASE2 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called HC010 combined with chemotherapy in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to find a safe dose and check for side effects. About 331 participants will take part, and resea…
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC